Access & Value (A&V), Outcomes and Evidence (O&E) Manager

Pfizer; United Kingdom; Hybrid; GBP 65,000 - 90,000; Full time

Job summary

Pfizer is seeking a Manager-level professional to lead an optimised evidence strategy for UK HTA submissions within the O&E team. You will identify gaps, prioritise impactful evidence, and plan real-world studies in close collaboration with HTA and A&A teams to align with UK launches and global strategies.

The role emphasizes experience in RWE, UK databases, and strong stakeholder engagement to deliver high-quality evidence for reimbursement and access decisions.

Qualifications

• Post-graduate qualification in epidemiology/public health or other relevant degree.
• Strong project management, strategic and analytic skills.
• Experience supporting RWE studies and HTA/market access.
• Able to manage multiple assets with cross-functional collaboration.

Responsibilities

• Develop evidence gap analyses and strategies for assets across therapy areas.
• Identify patient-centered study requirements for reimbursement with Outcomes Research scientists.
• Develop business cases to seek funding for studies and present impact on reimbursement.
• Lead RWE projects end-to-end, including vendor management and SOP/ABPI compliance.
• Maintain relationships with cross-functional teams to keep evidence plans aligned with business needs.
• Stay updated on UK datasets, analytics platforms, and RWE methods for faster evidence generation.
• Provide training to develop RWE methodology within the team.

Skills

Project management

Interpersonal skills

Stakeholder management

Data interpretation

Communication of complex data

Education

Post-graduate qualification in epidemiology/public health

Tools

UK datasets CPRD/HES/SACT

Job description

Role Summary:

You will be part of Pfizer’s dynamic market access, Access & Value UK, team and will have the important role of evaluating and delivering on the evidence needs for pre-marketed medicines in the UK. A&V comprises three sub-teams – Health Technology Assessment (HTA), Asset & Access (A&A) and Outcomes & Evidence (O&E). This role sits in the O&E team who lead the evidence generation needs to support reimbursement and access in the UK.

In this role, the primary function is to lead an optimised evidence strategy for the UK’s HTA submissions. This requires the individual to identify gaps in evidence, prioritise those which will make a difference to the likelihood of reimbursement and, if required, plan and deliver new real-world evidence (RWE) studies (such treatment patterns and healthcare resource use). To achieve this, the individual works hand-in-hand HTA and A&A to drive the overall reimbursement and access strategy which requires strong cross-functional engagement to ensure the strategies are aligned with the UK launch and wider Global strategies.

At Manager level, the individual is expected to be supported by a senior colleague from within the O&E team to develop their research methods capabilities, their understanding of market access and the applicability of RWE to optimising reimbursement. As such, we are seeking an individual who has experience of supporting RWE studies, preferably retrospective database studies in the UK and can demonstrate an understanding of robust scientific and methodological approaches to study design. An understanding of HTA/market access is preferable. They will be managing multiple pipeline assets and will therefore need excellent time management and prioritisation skills. Strong interpersonal skills to positively collaborate with multiple internal stakeholders and key external stakeholders will also be required to ensure that our work is comprehensive and valuable to patients as well as the UK business.

Role responsibilities :

• Develop thorough evidence gap analyses and corresponding evidence strategies (i.e. solutions for addressing gaps) for assets across different therapy areas
• Work with Outcomes Research scientists in O&E to identify and support patient-centered study requirements for reimbursement
• Develop business cases to seek funding for studies that clearly and succinctly convey the impact of evidence generation studies on reimbursement and access outcomes
• Lead RWE projects, with senior support, to a high-standard, end-to-end from conceptualisation to dissemination including management of vendors or internal teams to conduct RWE projects, management of internal processes to ensure compliance with SOPs and ABPI Code of Conduct where relevant
• Maintain excellent working relationships with cross-functional teams assigned to an asset to ensure evidence plans remain strategic for the business, keep them updated with evolutions in relevant evidence from across the business and report on progress with active studies
• Maintain and develop a working knowledge of advancements in UK datasets, analytical platforms and RWE methods and that can be utilised to accelerate or enhance evidence generation
• Source or provide appropriate training to develop skills and talent in RWE methodology.

Qualifications:

Must-Have

• Post-graduate qualification in epidemiology/public health or other relevant degree
• Some relevant experience across industry and/or consultancy in RWE and HTA/market access
• Supported/led observational research including UK databases (e.g. CPRD/HES/SACT) with deep understanding of study design, study protocols and analysis plans
• Strong project management, strategic and analytic skills, along with excellent interpersonal skills
• Strong internal and external stakeholder management skills to ensure consistency in alignment of the evidence strategy
• Ability to adapt and change strategies efficiently and pragmatically in response to shifts in market access needs
• Ability to convey complex data to technical and non-technical audiences
• Strong personal integrity and commitment to ethics and working in compliance with Pfizer policies and UK regulations

Purpose

Breakthroughs that change patients’ lives… At Pfizer we are apatient centric company, guided by our four values: courage, joy, equity and excellence. Our breakthrough culture lends itself to our dedication to transforming millions of lives.

Digital Transformation Strategy

One bold way we are achieving our purpose is through our company wide digital transformation strategy. We are leading the way in adopting new data, modelling and automated solutions to further digitize and accelerate drug discovery and development with the aim of enhancing health outcomes and the patient experience.

Flexibility

We aim to create a trusting, flexible workplace culture which encourages employees to achieve work life harmony, attracts talent and enables everyone to be their best working self.Let’s start the conversation!

Equal Employment Opportunity

We believe that a diverse and inclusive workforce is crucial to building a successful business. As an employer, Pfizer iscommitted to celebratingthis,in all itsforms – allowing for us to be as diverse as the patients and communities we serve. Together, we continue to build a culture that encourages, supports and empowers our employees.

DisAbility Confident

We are proud to be a Disability Confident Employer and we encourage you to put your best self forward with the knowledge and trust that we will make any reasonable adjustments necessary to support your application and future career. Our mission is unleashing the power of our people, especially those with unique superpowers. Your journey with Pfizer starts here!

To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers.

Market Access